Jeremy G. Chadwick is COO at Kymera Therapeutics, Inc. (KYMR). They have made 5 open-market trades across 1 company since 2009, most recently 2026-05-27.
CIK 0001388406
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KYMR | 44,018 | $4.6M |
| SNTA | 23,761 | — |
| Total | $4.6M |
Shares reported on the most recent Form 4, priced at the 2026-05-27 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KYMR | SELL · 10b5-1 | 2026-05-26 | 2026-05-27 | $79.92 | $1.4M | -9.7% | +31.7% | +54.9% |
| KYMR | SELL · 10b5-1 | 2026-04-22 | 2026-04-24 | $90.00 | $27K | +1.8% | -4.8% | +30.1% |
| KYMR | SELL · 10b5-1 | 2026-04-14 | 2026-04-16 | $90.00 | $590K | -4.5% | -9.2% | +30.0% |
| KYMR | SELL · 10b5-1 | 2026-03-31 | 2026-04-01 | $85.43 | $1.9M | +8.6% | -2.5% | +38.6% |
| KYMR | SELL · 10b5-1 | 2026-03-23 | 2026-03-25 | $78.01 | $18.0M | +9.8% | +9.5% | +26.7% |
| KYMR | SELL | 2026-03-11 | 2026-03-11 | $83.30 | $2.1M | -3.7% | +6.4% | -3.6% |
| KYMR | SELL | 2026-03-02 | 2026-03-04 | $86.54 | $516K | -6.9% | -0.3% | -16.5% |
| KYMR | SELL | 2025-05-23 | 2025-05-23 | $29.30 | $151K | +58.1% | +53.5% | +41.3% |
| KYMR | SELL | 2025-03-03 | 2025-03-03 | $30.45 | $42K | +15.1% | -9.3% | +48.4% |
| KYMR | SELL | 2024-05-23 | 2024-05-23 | $34.99 | $180K | -1.5% | -8.5% | +41.2% |
| SNTA | SELL · 10b5-1 | 2009-01-05 | 2009-01-06 | $6.20 | $28K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.